logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Client Press Releases
Filter

Client Press Releases

Categories

Sectors

Locations

Exchange

Resverlogix Corp TSX:RVX Pharmaceutical, Biotechnology, 医药,生物科技

Resverlogix Closes $50 Million Private Placement With Hepalink and Eastern Capital

Jul 22, 2015

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial

Jul 22, 2015

Dynacor Gold Mines Inc TSX:DNG Gold, Precious Metals, 黄金,贵金属

Dynacor: New Diamond Drilling Results Extend the Manto Dorado to the SW and Discover a New Gold Mineralized Manto Raquel

Jul 17, 2015

Fission Uranium Corp TSX:FCU

Fission’s First Summer Holes Hit High-Grades at R600W and R780E

Jul 14, 2015

Dynacor Gold Mines Inc TSX:DNG Gold, Precious Metals, 黄金,贵金属

DYNACOR: Marc Duchesne Elected to the Board and Appointed to the Audit Committee

Jul 10, 2015

Resverlogix Corp TSX:RVX Pharmaceutical, Biotechnology, 医药,生物科技

Resverlogix Closes License Agreement and Enters Into Definitive Stock Purchase Agreement With Hepalink

Jul 9, 2015

Fission Uranium Corp TSX:FCU

Denison and Fission Announce Transaction to Create Leading Diversified Uranium Company

Jul 7, 2015

Search Minerals Inc TSXV:SMY Energy Metals, Rare Earth, 能源金属,稀土

Search Announces Grant of Stock Options

Jul 4, 2015

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis

Jul 1, 2015

Fission Uranium Corp TSX:FCU

Fission Hits 8.04% U3O8 Over 19.5m in 3.82% U3O8 Over 43.5m; Expands Triple R Footprint

Jun 30, 2015

Search Minerals Inc TSXV:SMY Energy Metals, Rare Earth, 能源金属,稀土

Search Minerals owns 100% of Red Wine Complex Property with purchase of Great Western Minerals’ working interest

Jun 30, 2015

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Life Sciences Inc. Announces Closing of Brokered and Non-brokered Private Placement

Jun 27, 2015

Dynacor Gold Mines Inc TSX:DNG Gold, Precious Metals, 黄金,贵金属

Dynacor Shareholders Deliver Powerful Message With Unprecedented Win in Canadian Proxy Fight

Jun 24, 2015

Resverlogix Corp TSX:RVX Pharmaceutical, Biotechnology, 医药,生物科技

Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority

Jun 23, 2015

Fission Uranium Corp TSX:FCU

Fission 60 Hole Program to Target R600W and Triple R Growth Plus Regional Targets

Jun 19, 2015

Dynacor Gold Mines Inc TSX:DNG Gold, Precious Metals, 黄金,贵金属

Dynacor Urges Its Shareholders to Vote the WHITE Proxy in Support of Management

Jun 19, 2015

Manitok Energy Inc TSXV:MEI Oil & gas, Natural Gas, 能源,油气,石油,天然气

Manitok Energy Inc. Announces the Closing of the Final Tranche of the Equity Financing, Update on the Wayne Acquisition and a Financial Update

Jun 18, 2015

Stornoway Diamond Corp TSX:SWY

Stornoway Announces Fourth Quarter and Fiscal Year 2015 Results

Jun 18, 2015

  • ‹‹ Previous
  • 296
  • 297
  • 298
  • 299
  • 300
  • 301
  • 302
  • 303
  • 304
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada